KAI Manufacturing India has recently appointed Keijiro Takasago as their new Managing Director. With thirty years in corporate banking and international business leadership behind him, Takasago is set to steer the renowned razor-making company forward. According to a feature by […]
Keijiro Takasago Appointed as Managing Director of KAI India Read More »
Accenture has revealed its nomination of Masahiko Uotani and Jennifer Nason for election to its Board of Directors following their annual shareholder meeting. Uotani, who is 70, currently holds the position of Chairman and CEO at Shiseido, while 64-year-old Nason
Shiseido’s Uotani Nominated to Accenture Board Read More »
Individualized health coaching options are now available for purchase on questhealth.com. Offered through Pack Health, a subsidiary of Quest Diagnostics known for its evidence-based patient interaction services, the platform pairs users with certified health coaches. These professionals offer focused support,
***Solventum (NYSE: SOLV), formerly the Health Care division of 3M, has initiated a series of workforce reductions.*** The Star Tribune of Minnesota first reported the development through a video message by CEO Bryan Hanson directed to the Twin Cities headquarters’
Staff Reductions Announced by Solventum Read More »
Today, Withings revealed it has acquired approximately $22.5 million in backing as part of a fresh initiative supported by the French government. Through the France 2030 program, Withings is set to embark on “Project Deep” ( DE vice as a
Withings Secures $22.5M for AI and Medical Device Advancements Read More »
Minneapolis-based ShiraTronics has officially commenced its pivotal FDA investigational device exemption (IDE) trial, aiming to assess its neuromodulation therapy for chronic migraines. The RELIEV-CM2 study marks the beginning of in-depth evaluation regarding the long-term safety and performance of this treatment.
ShiraTronics Kicks Off FDA IDE Trial for Implantable Neuromodulation Therapy Read More »
Edwards Lifesciences (NYSE:EW) shared its ambitious growth trajectory as it transitions into a dedicated structural heart enterprise by 2025. This pivot follows the $4.2 billion divestment of its Critical Care division to BD, inciting a 3% global workforce reduction and
GE HealthCare, renowned for its innovations in medical technology, pharmaceutical diagnostics, and digital solutions, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for approval of CleaRecon DL. This cutting-edge deep learning technology aims to uplift
RESTEM, a biotechnological firm at the clinical-stage, dedicated to crafting innovative cell therapies that are readily available and aim to regulate the immune response, has disclosed that the United States Food and Drug Administration (FDA) has bestowed Orphan Drug Designation
Dentalkart, the pioneering and largest online hub for dental products in India, has garnered Rs. 85 crore in a recent financing round. This investment, headed by international investors Malabar Investment and Whiteoak, underscores the company’s dedication to transforming the dental